Placenta, Abnormal Conception, and Prematurity

Sergi, Consolato

doi:10.1007/978-3-662-59169-7_18

Cited by 1 publication

(1 citation statement)

References 287 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…FGR and PE don't aggravate the mother's condition, contrary to popular perception. Mothers with perinatal eosinophilia (PE) have stable fetal growth percentiles [4].…”

Section: Introductionmentioning

confidence: 99%

Different clinical presentation of two pregnancy syndromes: Similar pro and antiangiogenic characteristics near delivery: Fetal growth preeclampsia

Raman

Prasad²,

Vishwanath³

2023

ijhs

View full text Add to dashboard Cite

This research aimed to determine if there was a statistically significant distinction between the serum anti- but also pro-angiogenic chemical ratios among pregnant women having preeclampsia and/or fetal growth limitation, two clinical subgroups of placental ischemia syndrome. We conducted a prospective case-control study that looked at 77 singleton pregnancies and compared them with and without preeclampsia with 77 singleton pregnancies with and without healthy fetuses, matching for gestational age. All pregnant participants in the trial were analyzed to determine the presence or absence of adverse outcomes. Because once in comparison to the control group, the study participants had higher levels of obtainable endoglin dissolution and the ratio of fms-like tyrosine kinase-1 (sFlt-1) to trophoblastic growth factor. Despite the fact that experimental groups received a same quantity of placental growth factor, this was the case (PlGF). sFlt-1 to PlGF ratio as well as the PE without accompanying FGR cohort were the two areas in which the most prominent outliers were discovered. Since preeclamptic persons have the greatest sFlt-1 levels, this factor may be responsible for the development of PE in the mother due to ischemic placental disease.

show abstract

“…FGR and PE don't aggravate the mother's condition, contrary to popular perception. Mothers with perinatal eosinophilia (PE) have stable fetal growth percentiles [4].…”

Section: Introductionmentioning

confidence: 99%